Home / Inspections / 1099764

FDA Inspection 1099764 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3006611178

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on July 30, 2019 in Ammon, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 30, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ammon, ID (United States)

Facility

Other inspections at this facility

  • 975877 (NAI Wed Jun 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934717 (NAI Thu Jul 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 844248 (NAI Wed Aug 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 712228 (NAI Wed Mar 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 599120 (VAI Thu Jun 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources